Dr. Feng Ding joined Chengdu New Radiomedicine Technology Co., Ltd. in 2023 and is the Senior Vice President.

Dr. Ding is a PhD in Biology from the University of Pittsburgh and holds a bachelor's degree in Biology from Tsinghua University. Dr. Ding was the Chief Technology Officer at the University of Pittsburgh, Postdoctoral Fellow of Stanford University, Associate Professor and Assistant Dean of the School of Life Sciences of Xiamen University, and General Manager of Yakobo Laboratory (and Associate Researcher of Tsinghua Yangtze River Delta Research Institute, Zhejiang Province). She is experienced in genetics, oncology, and molecular biology. Dr. Ding studied with Professor Uta Francke, a renowned expert in human genetics at Stanford University School of Medicine. Dr. Ding’s main research interests include: chromosomal aberration genetics, epigenetics, non-coding RNAs, animal models, tumor signaling pathways, and diagnostic technology development, etc.